Dan Elkes works in the biotechnology industry as the Vice President of Portfolio and Program Management at Altos Labs. He previously led Portfolio Strategy and Operations for Genentech Research and Early Development (gRED). Dan was part of the team that developed the revolutionary cancer immunotherapy treatments Ipilimumab and nivolumab at Medarex. Prior to Medarex, Dan was a scientist at Exelixis and a management consultant.
In addition to his work in biotech, Dan has been heavily involved in the anti-trafficking/anti-modern day slavery movement, founding the Freedom from Slavery Forum, serving as the Chair of the Board of Directors for Free the Slaves, and supporting numerous other organizations in this space. He received his Ph.D. in genetics from Harvard University and studied Molecular Biology and Public Policy at Princeton University.
